VITAMIN AD INJECTION

Manufacturer
Sparhawk Laboratories, Inc.
Effective date
2017-06-14
Label type
OTC ANIMAL DRUG LABEL
Version
9
Source
full-release
Hydrated at
2026-06-01 02:40:05

Label at a glance#

ProductVITAMIN AD
Active ingredientRETINOL, CHOLECALCIFEROL
Label structure6 sections

Dosage and administration

Inject intramuscularly or subcutaneously preferably  in the neck area using aseptic technique. Calves - 1/2 to 1 mL, Yearling Cattle -1 to 2 mL Adult Cattle - 2 to 4 mL, These suggested dosage may be repeated after 60 days, if necessary.

Storage and handling

Store at controlled room temperature between 15 o and 30 o C (59-86 o F). Protect from light and excessive heat. TAKE TIME OBSERVE LABEL DIRECTIONS

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

INDICATIONS

For use as a supplemental nutritive source of vitamins A and D in cattle.

CAUTION

PRECAUTIONS SECTION

Do not inject into meat animals within 60 days of marketing. 

Administration of this product to well nourished animals may cause hypervitaminosis D which may result in hypercalcemia.  This condition may be harmful to the animal.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Inject intramuscularly or subcutaneously preferably  in the neck area using aseptic technique.

Calves- 1/2 to 1 mL,
Yearling Cattle-1 to 2 mL
Adult Cattle- 2 to 4 mL,

These suggested dosage may be repeated after 60 days, if necessary.

ACTIVE INGREDIENTS

DOSAGE FORMS & STRENGTHS SECTION

Each mL of sterile solution contains:
Vitamin A  . . . . . . . . . 500,000 IU
Vitamin D3  . . . . . . . . . 75,000 IU
In an emulsifiable base with vitamin E (antioxidant), N-methylpyrrolidone, polyoxyethylated (30) castor oil, propylene glycol dicaprylate, polyoxyethylene (20) sorbitan monooleate and benzyl alcohol 2%.

STORAGE

STORAGE AND HANDLING SECTION

Store at controlled room temperature between 15o and 30oC (59-86oF).

Protect from light and excessive heat.

TAKE TIME OBSERVE LABEL DIRECTIONS

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SLI-Vit ADSLI-Vit AD

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
999793vitamin A 500,000 UNT/ML / vitamin D3 75,000 UNT/ML Injectable SolutionPSN9
999793cholecalciferol 75000 UNT/ML / vitamin A 500000 UNT/ML Injectable SolutionSCD9
999793retinol 500,000 UNT/ML / vitamin D3 75,000 UNT/ML Injectable SolutionSY9

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CHOLECALCIFEROL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
60c52429-fcef-eb54-2387-43bc9e4f296bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58005-332-04VITAMIN AD100 mL in 1 VIALINJECTION1009
58005-332-05VITAMIN AD250 mL in 1 VIALINJECTION2509
58005-332-06VITAMIN AD500 mL in 1 VIALINJECTION5009

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58005-332VITAMIN AD (RETINOL CHOLECALCIFEROL) INJECTION [SPARHAWK LABORATORIES, INC.]93 package rows20170614_37594875-b01e-40c1-b731-a778054c1296.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CHOLECALCIFEROLACTIVE INGREDIENT1C6V77QF416
RETINOLACTIVE INGREDIENTG2SH0XKK916
CHOLECALCIFEROLACTIVE MOIETY1C6V77QF416
RETINOLACTIVE MOIETYG2SH0XKK916

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
58005-33258005-332-04, 58005-332-05, 58005-332-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
RETINOLG2SH0XKK91ACTIB
CHOLECALCIFEROL1C6V77QF41ACTIB

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.